Oral Surgery

FDA Rescinds Warning Letter Regarding Exparel Use

By December 15, 2015

Pacira Pharmaceuticals have reached an amicable resolution with the Food and Drug Administration (FDA) in their lawsuit concerning the indication of the analgesic, Exparel (bupivacaine liposome injectable suspension).